梅斯医学设立“话题”,你可以自己拥有自己的话题

2020-06-15 MedSci MedSci原创

梅斯医学设立“话题”功能,每个人均可创建自己的话题,创立话题非常简单。只要在网站任何地方(评论,期刊评论,以及其它地方),在输入的内容中##,隔开内容,##中间的即是话题。例如

梅斯医学设立“话题”功能,每个人均可创建自己的话题,创立话题非常简单。只要在网站任何地方(评论,期刊评论,以及其它地方),在输入的内容中##,隔开内容,##中间的即是话题。例如:

新冠肺炎的话题:#新冠肺炎#

新辅助免疫治疗的话题:#新辅助免疫治疗#

你不也试试?

 

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1221900, encodeId=4fe1122190094, content=<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>学习建立话题, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82e68113218, createdName=ms4000001438501191, createdTime=Tue May 24 08:11:45 CST 2022, time=2022-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186481, encodeId=dd6811864812a, content=<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fb9e5201688, createdName=1473e499m15暂无昵称, createdTime=Thu Jan 20 16:40:06 CST 2022, time=2022-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1277118, encodeId=a24412e7118fa, content=<a href='/topic/show?id=bde16242956' target=_blank style='color:#2F92EE;'>#梅斯#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62429, encryptionId=bde16242956, topicName=梅斯)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Wed Jun 17 04:17:51 CST 2020, time=2020-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=602308, encodeId=179760230838, content=<a href='/topic/show?id=bdeb1e018cc' target=_blank style='color:#2F92EE;'>#T-DM1#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17018, encryptionId=bdeb1e018cc, topicName=T-DM1)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200522/f1126cd98e1448048cb906afa4286e83/fs.jpg, createdBy=2d095296474, createdName=皮大叉, createdTime=Mon Jun 15 14:36:58 CST 2020, time=2020-06-15, status=1, ipAttribution=)]
    2022-05-24 ms4000001438501191

    #学习#学习建立话题

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1221900, encodeId=4fe1122190094, content=<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>学习建立话题, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82e68113218, createdName=ms4000001438501191, createdTime=Tue May 24 08:11:45 CST 2022, time=2022-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186481, encodeId=dd6811864812a, content=<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fb9e5201688, createdName=1473e499m15暂无昵称, createdTime=Thu Jan 20 16:40:06 CST 2022, time=2022-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1277118, encodeId=a24412e7118fa, content=<a href='/topic/show?id=bde16242956' target=_blank style='color:#2F92EE;'>#梅斯#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62429, encryptionId=bde16242956, topicName=梅斯)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Wed Jun 17 04:17:51 CST 2020, time=2020-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=602308, encodeId=179760230838, content=<a href='/topic/show?id=bdeb1e018cc' target=_blank style='color:#2F92EE;'>#T-DM1#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17018, encryptionId=bdeb1e018cc, topicName=T-DM1)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200522/f1126cd98e1448048cb906afa4286e83/fs.jpg, createdBy=2d095296474, createdName=皮大叉, createdTime=Mon Jun 15 14:36:58 CST 2020, time=2020-06-15, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1221900, encodeId=4fe1122190094, content=<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>学习建立话题, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82e68113218, createdName=ms4000001438501191, createdTime=Tue May 24 08:11:45 CST 2022, time=2022-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186481, encodeId=dd6811864812a, content=<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fb9e5201688, createdName=1473e499m15暂无昵称, createdTime=Thu Jan 20 16:40:06 CST 2022, time=2022-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1277118, encodeId=a24412e7118fa, content=<a href='/topic/show?id=bde16242956' target=_blank style='color:#2F92EE;'>#梅斯#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62429, encryptionId=bde16242956, topicName=梅斯)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Wed Jun 17 04:17:51 CST 2020, time=2020-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=602308, encodeId=179760230838, content=<a href='/topic/show?id=bdeb1e018cc' target=_blank style='color:#2F92EE;'>#T-DM1#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17018, encryptionId=bdeb1e018cc, topicName=T-DM1)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200522/f1126cd98e1448048cb906afa4286e83/fs.jpg, createdBy=2d095296474, createdName=皮大叉, createdTime=Mon Jun 15 14:36:58 CST 2020, time=2020-06-15, status=1, ipAttribution=)]
    2020-06-17 一闲
  4. [GetPortalCommentsPageByObjectIdResponse(id=1221900, encodeId=4fe1122190094, content=<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>学习建立话题, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82e68113218, createdName=ms4000001438501191, createdTime=Tue May 24 08:11:45 CST 2022, time=2022-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186481, encodeId=dd6811864812a, content=<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fb9e5201688, createdName=1473e499m15暂无昵称, createdTime=Thu Jan 20 16:40:06 CST 2022, time=2022-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1277118, encodeId=a24412e7118fa, content=<a href='/topic/show?id=bde16242956' target=_blank style='color:#2F92EE;'>#梅斯#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62429, encryptionId=bde16242956, topicName=梅斯)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Wed Jun 17 04:17:51 CST 2020, time=2020-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=602308, encodeId=179760230838, content=<a href='/topic/show?id=bdeb1e018cc' target=_blank style='color:#2F92EE;'>#T-DM1#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17018, encryptionId=bdeb1e018cc, topicName=T-DM1)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200522/f1126cd98e1448048cb906afa4286e83/fs.jpg, createdBy=2d095296474, createdName=皮大叉, createdTime=Mon Jun 15 14:36:58 CST 2020, time=2020-06-15, status=1, ipAttribution=)]
    2020-06-15 皮大叉

相关资讯

梅斯医学网站增加“话题”功能,随时拥有属于自己的话题

为了更好方便大家交流,此次随着网站升级,特别增加了“话题”功能。

老话题新见解 知名院长集中支招学科建设

“学科评估与排行榜,真正关心的应该是学科发展,而不是医院排名。”复旦大学医院管理研究所高解春所长,在7月6日,由海南博鳌医学创新研究院学术主办,健康界主办,北京诺华制药有限公司特别支持的“医院专科发展力沙龙”会议上这样说道。本次会议吸引了众多医院管理者与学者出席,就学科建设的形式、人才、协作、平台和信息化等方面各抒己见,为与会嘉宾带来诸多借鉴经验。2019年国家卫生健康委员会规划的十项重点工作